Skip to main content

Table 4 Intraoperative findings

From: The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage

Variables Group A Group B Group C Group A vs B Group A vs C Group B vs C
Intraoperative bleeding 12(75%) 2(12.5%) 1(6.25%) P = 0.001 P = 0.000 P = 1
Endodiathermy 9(56.25%) 1(6.25%) 1(6.25%) P = 0.006 P = 0.006 P = 1
Iatrogenic break 5(31.25%) 1(6.25%) 0(0%) P = 0.172 P = 0.043 P = 1
Relaxing retinotomy 1(6.25%) 0(0%) 0(0%) P = 1 P = 1 P = 1
Silicone-oil tamponade 9(56.25%) 2(12.5%) 2(12.5%) P = 0.023 P = 0.023 P = 1
Balanced salt solution (BSS) 5(31.25%) 11(68.75%) 10(62.5%)    
Sterile air 2(12.5%) 3(18.75%) 4(25%)    
Surgical mean time (min) 110.625 ± 21.975 96.563 ± 16.705 86.25 ± 18.841 P = 0.05 P = 0.002 P = 0.112